← Leaderboards
Juan M Melero-Martin
Boston Children'S Hospital
$14,050,839
Attributed
$17,362,425
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,362,425 · 10
By mechanism
R01$15,976,854 · 7
R00$718,821 · 1
R21$486,750 · 1
K99$180,000 · 1
Top collaborators
- William T Pu4 shared
- Minglin Ma3 shared
- Ke Yuan2 shared
- Bo Wang1 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Xiaocheng Charlie Dong$10,212,995
- Diane Renee Bielenberg$4,392,792
- Timothy Klouda$375,945
- Ke Yuan$3,014,603
- Arin K. Greene$7,502,379
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsIn VivoCellsEndothelial CellsImplantationStem CellsTechnologyPhenotypeTissuesTransplantationImmunodeficient MouseInduced Pluripotent Stem CellSubcutaneousPropertyNatural RegenerationVascularizationBaseGenesIn VitroAffectMorbidity - Disease RateCell TypeOverexpressionEngraftment
Grant awards (37)
Pericyte contribution to capillary remodeling in pulmonary arterial hypertension$798,079
R01 · FY2025 · HL
A Novel Transcription Factor-Driven Approach for Mural Progenitor Cells Generation$638,118
R01 · FY2025 · HL · contact PI
Human endothelial cell regulation of ossification$398,179
R01 · FY2025 · AR · contact PI
Pericyte contribution to capillary remodeling in pulmonary arterial hypertension$806,127
R01 · FY2024 · HL
Vascular networks genetically engineered for protein drug delivery$651,169
R01 · FY2024 · HL · contact PI
A Novel Transcription Factor-Driven Approach for Mural Progenitor Cells Generation$638,118
R01 · FY2024 · HL · contact PI
Regulation of endothelial cell specification$583,704
R01 · FY2024 · HL
Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria$563,978
R01 · FY2024 · HL · contact PI
Human endothelial cell regulation of ossification$429,147
R01 · FY2024 · AR · contact PI
Vascular networks genetically engineered for protein drug delivery$667,097
R01 · FY2023 · HL · contact PI
Regulation of endothelial cell specification$603,584
R01 · FY2023 · HL
Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria$575,487
R01 · FY2023 · HL · contact PI
Human endothelial cell regulation of ossification$442,420
R01 · FY2023 · AR · contact PI
Regulation of endothelial cell specification$652,018
R01 · FY2022 · HL
Vascular networks genetically engineered for protein drug delivery$572,353
R01 · FY2022 · HL · contact PI
Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria$533,366
R01 · FY2022 · HL · contact PI
Human endothelial cell regulation of ossification$442,420
R01 · FY2022 · AR · contact PI
Vascular networks genetically engineered for protein drug delivery$662,263
R01 · FY2021 · HL · contact PI
Regulation of endothelial cell specification$626,778
R01 · FY2021 · HL
Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria$533,366
R01 · FY2021 · HL · contact PI
Vascular niche bioengineering for human bone regeneration$389,400
R01 · FY2020 · AR · contact PI
Vascular networks genetically engineered for protein drug delivery$442,500
R01 · FY2019 · HL · contact PI
Vascular niche bioengineering for human bone regeneration$389,400
R01 · FY2019 · AR · contact PI
Vascular networks genetically engineered for protein drug delivery$442,500
R01 · FY2018 · HL · contact PI
Vascular niche bioengineering for human bone regeneration$389,400
R01 · FY2018 · AR · contact PI
Vascular networks genetically engineered for protein drug delivery$442,500
R01 · FY2017 · HL · contact PI
Vascular niche bioengineering for human bone regeneration$389,400
R01 · FY2017 · AR · contact PI
Host neutrophils as direct mediators of tissue graft revascularization$221,250
R21 · FY2017 · AI · contact PI
Vascular networks genetically engineered for protein drug delivery$442,500
R01 · FY2016 · HL · contact PI
Vascular niche bioengineering for human bone regeneration$389,400
R01 · FY2016 · AR · contact PI
Host neutrophils as direct mediators of tissue graft revascularization$265,500
R21 · FY2016 · AI · contact PI
Vascular networks genetically engineered for protein drug delivery$442,083
R01 · FY2015 · HL · contact PI
Engineering vascularized tissue in vivo using postnatal progenitor cells$227,134
R00 · FY2013 · EB · contact PI
Engineering vascularized tissue in vivo using postnatal progenitor cells$244,341
R00 · FY2012 · EB · contact PI
Engineering vascularized tissue in vivo using postnatal progenitor cells$247,346
R00 · FY2011 · EB · contact PI
Engineering vascularized tissue in vivo using postnatal progenitor cells$90,000
K99 · FY2010 · EB · contact PI
Engineering vascularized tissue in vivo using postnatal progenitor cells$90,000
K99 · FY2009 · EB · contact PI